1. Home
  2. HCWB vs WTO Comparison

HCWB vs WTO Comparison

Compare HCWB & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • WTO
  • Stock Information
  • Founded
  • HCWB 2018
  • WTO 2008
  • Country
  • HCWB United States
  • WTO China
  • Employees
  • HCWB N/A
  • WTO N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • WTO Consumer Electronics/Appliances
  • Sector
  • HCWB Health Care
  • WTO Technology
  • Exchange
  • HCWB Nasdaq
  • WTO Nasdaq
  • Market Cap
  • HCWB 10.8M
  • WTO 12.6M
  • IPO Year
  • HCWB 2021
  • WTO 2021
  • Fundamental
  • Price
  • HCWB $5.59
  • WTO $1.34
  • Analyst Decision
  • HCWB Strong Buy
  • WTO
  • Analyst Count
  • HCWB 1
  • WTO 0
  • Target Price
  • HCWB $35.00
  • WTO N/A
  • AVG Volume (30 Days)
  • HCWB 5.7M
  • WTO 519.6K
  • Earning Date
  • HCWB 08-18-2025
  • WTO 09-23-2025
  • Dividend Yield
  • HCWB N/A
  • WTO N/A
  • EPS Growth
  • HCWB N/A
  • WTO N/A
  • EPS
  • HCWB N/A
  • WTO N/A
  • Revenue
  • HCWB $832,841.00
  • WTO $34,589,265.00
  • Revenue This Year
  • HCWB $178.36
  • WTO N/A
  • Revenue Next Year
  • HCWB N/A
  • WTO N/A
  • P/E Ratio
  • HCWB N/A
  • WTO N/A
  • Revenue Growth
  • HCWB N/A
  • WTO 54.01
  • 52 Week Low
  • HCWB $2.77
  • WTO $0.75
  • 52 Week High
  • HCWB $100.80
  • WTO $8.56
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 60.31
  • WTO 68.75
  • Support Level
  • HCWB $3.25
  • WTO $1.03
  • Resistance Level
  • HCWB $6.66
  • WTO $1.40
  • Average True Range (ATR)
  • HCWB 0.77
  • WTO 0.12
  • MACD
  • HCWB -0.05
  • WTO 0.05
  • Stochastic Oscillator
  • HCWB 57.07
  • WTO 70.76

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: